Serum levels of CA-125 in patients with endometriosis: a preliminary report.
Seven out of 8 patients with endometriosis demonstrated levels of CA-125 antigen above 35 U/ml. None of 15 patients with other benign gynecologic diagnoses demonstrated elevated levels. This antigen has been proposed as a tumor marker for epithelial carcinoma and other gynecologic neoplasms. However, it cannot be used to differentiate clinically between cancer and endometriosis.
Giudice
L C
LC
Jacobs
A
A
Pineda
J
J
Bell
C E
CE
Lippmann
L
L
D000293:Adolescent; D000328:Adult; D000368:Aged; D000951:Antigens, Neoplasm / Q000032:analysis*; D000954:Antigens, Surface / Q000032:analysis*; D015295:Antigens, Tumor-Associated, Carbohydrate; D002277:Carcinoma / Q000276:immunology; D003937:Diagnosis, Differential; D004715:Endometriosis / Q000175:diagnosis / Q000276:immunology* / Q000473:pathology; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000276:immunology; D008875:Middle Aged; D010001:Osteitis Deformans / Q000276:immunology; D010048:Ovarian Cysts / Q000276:immunology; D010051:Ovarian Neoplasms / Q000276:immunology; D011379:Prognosis; D014594:Uterine Neoplasms / Q000276:immunology
D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D015295:Antigens, Tumor-Associated, Carbohydrate